For decades, cancer treatment has focused on surgery, chemotherapy, radiation, and newer forms of immunotherapy. Yet many tumors still find ways to hide from the immune system, growing quietly while the body struggles to detect them. Now, scientists in China believe they have found a new way to expose cancer—by turning the body’s allergy cells into precise cancer fighters.
Researchers from Zhejiang University and the First Hospital of China Medical University have showed a new cancer treatment strategy built around mast cells, immune cells best known for triggering allergic reactions.
Mast cells usually react to pollen, food, or dust by releasing chemicals that cause swelling, redness, and itching. These reactions often feel unpleasant, but scientists now believe that the same process can be used to fight cancer—if it is carefully controlled and aimed at tumors. 
According to the research team, the key lies in forcing cancer out of hiding. Tumors often suppress the immune system around them, creating a cold, silent environment where immune cells fail to respond. By triggering a targeted, allergy-like inflammation inside the tumor, researchers say they can break this silence.
Instead of reacting to allergens, the scientists modified mast cells using special antibodies. These antibodies are designed to recognize proteins found specifically on cancer cells. Once altered, the mast cells no longer respond to harmless triggers. They now focus entirely on tumors.
After entering the body, the modified mast cells travel through the bloodstream until they reach a tumor. When they come into direct contact with cancer cells, they activate and release inflammatory signals at that exact location.
This controlled reaction transforms the tumor environment. As described by the researchers, this allergic-like response “heats up” the tumour, making it visible and vulnerable to immune cells that previously could not recognise it.
This heating effect does not burn tissue. Instead, it changes the chemical signals around the tumor, drawing immune cells into the area and alerting them to the threat. Immune cells that once passed by without reacting can now see the cancer clearly and begin attacking it.
Beyond inflammation, the scientists made another important discovery. Mast cells can also act as safe transport vehicles for oncolytic viruses—viruses that selectively infect and destroy cancer cells while sparing healthy tissue.
One of the biggest challenges with oncolytic virus therapy is survival in the bloodstream. The immune system often detects and destroys these viruses before they reach tumors. Mast cells solve this problem.
The researchers found that oncolytic viruses can hide inside mast cells as they move through the body. Protected from immune attack, the viruses remain inactive until the mast cells reach the tumor. Once activated inside the tumor environment, the mast cells release the viruses, allowing them to infect and destroy cancer cells directly.
Experts say this dual function—triggering inflammation and delivering viruses—makes mast cells a powerful new tool in cancer therapy. It also opens the door to truly personalized treatment.
The research team explained that this technology allows therapy to be adjusted quickly based on a patient’s specific tumor markers. Different antibodies can be attached to mast cells depending on the type of cancer, allowing for highly targeted treatment with fewer side effects.
Looking ahead, scientists believe this mast cell-based platform could do much more than carry viruses. According to the report, it could also deliver drugs, proteins, or nanomedicines directly into tumors, releasing them only when they reach the correct location.
This targeted delivery could reduce damage to healthy tissues and increase the effectiveness of treatment. It also offers hope for patients whose cancers do not respond well to existing therapies.
The team is now focused on moving this discovery from the lab to the clinic. They plan to actively develop the method for rapid use in medical practice, create algorithms that support treatment personalization, and study how mast cell therapy can work alongside current immunotherapies.
If successful, this approach could mark a major shift in how cancer is treated. By using the body’s own immune cells in smarter, more precise ways, researchers are finding new paths to fight one of the world’s most challenging diseases.
